Héroux-Devtek Inc. (TSE:HRX – Get Free Report) hit a new 52-week high on Tuesday . The company traded as high as C$31.99 and last traded at C$31.94, with a volume of 21339 shares traded. The stock had previously closed at C$31.88.
Analyst Upgrades and Downgrades
Separately, TD Securities downgraded Héroux-Devtek from a “buy” rating to a “sell” rating and raised their price objective for the company from C$28.00 to C$32.50 in a research report on Friday, July 12th.
Check Out Our Latest Analysis on HRX
Héroux-Devtek Stock Performance
Héroux-Devtek (TSE:HRX – Get Free Report) last issued its quarterly earnings results on Tuesday, August 6th. The company reported C$0.39 earnings per share for the quarter, topping the consensus estimate of C$0.26 by C$0.13. Héroux-Devtek had a net margin of 7.07% and a return on equity of 11.18%. The company had revenue of C$174.00 million for the quarter, compared to the consensus estimate of C$159.00 million. As a group, sell-side analysts forecast that Héroux-Devtek Inc. will post 1.5813492 earnings per share for the current year.
Héroux-Devtek Company Profile
Héroux-Devtek Inc engages in the design, development, manufacture, finishing, assembling, and repair and overhaul of aircraft landing gears, hydraulic and electromechanical flight control actuators, custom ball screws, and fracture-critical components. The company serves commercial and defence sectors of the aerospace market.
Recommended Stories
- Five stocks we like better than Héroux-Devtek
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- Biohaven Stock Soars on Drug Trial Results: Time to Jump In?
- Following Congress Stock Trades
- Is AMD a Legitimate Threat to NVIDIA? What Investors Should Watch
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Novo Nordisk’s Setback Won’t Last: A Game-Changing Drug Emerges
Receive News & Ratings for Héroux-Devtek Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Héroux-Devtek and related companies with MarketBeat.com's FREE daily email newsletter.